New study aims to reduce uterine scarring after pregnancy complications
NCT ID NCT07421895
First seen Feb 22, 2026 · Last updated May 16, 2026 · Updated 9 times
Summary
This study looks at the best way to treat retained products of conception (RPOC), tissue left in the uterus after pregnancy. It compares waiting with medication versus immediate surgery to see which approach causes less scarring and better protects future fertility. 600 participants will be followed to track uterine health and pregnancy rates.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETAINED PRODUCTS OF CONCEPTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Third Xiangya Hospital of Central South University
RECRUITINGChangsha, Hunan, 410013, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.